On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
On Sept. 6, 2021, Pfizer and BioNTech announced that they had submitted a variation to the European Medicines…
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
On Aug. 30, 2021, the United Nations announced the global phase-out of leaded fuel, a milestone for multilateralism,…
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study from found that blood…
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
On Aug. 26, 2021, Inovio Pharma announced that it had received regulatory authorization from Brazil’s ANVISA (Agencia Nacional…
On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…
On Aug. 25, 2021, Moderna announced it had completed the rolling submission process for its Biologics License Application…
On Aug. 25, 2021, Pfizer and BioNTech announced the initiation of a supplemental Biologics License Application (sBLA) to…
On Aug. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
On Aug. 20, 2021, Amyris announced promising in-vivo results in a study of its licensed RNA vaccine through…
On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…
On Aug. 16, 2021, Moderna announced a revised supply agreement with the Government of Canada for up to…
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
On Aug. 13, 2021, Moderna announced that the Food and Drug Administration (FDA) had approved an update to…
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…
On Aug. 12, 2021, Moderna announced the publication of new data on the durability of the Moderna COVID-19…
On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Aug. 10, 2021, Moderna announced a Memorandum of Understanding (MoU) with the government of Canada to build…
On Aug. 9, 2021, Moderna announced that the Therapeutic Goods Administration (TGA) had granted provisional registration to the…
On Aug. 9, 2021, Inovio Pharma announced that it had received regulatory allowance for two clinical trials investigating…
On Aug. 6, 2021, BD (Becton, Dickinson) and CerTest Biotec announced the CE mark for a molecular test…
On Aug. 5, 2021, Novavax announced preliminary data demonstrating that a single booster dose of its recombinant nanoparticle…
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…